Patients remaining abacteriuric after 12 months Methenamine hippurate versus any antibiotic showed a trend to benefit for methenamine hippurate, but a non-statistically significant difference (RR 0.80, 95% CI = 0.62 to 1.03), with low heterogeneity (23%) ( Figure 3 ).
← all excerpts
Use of methenamine hippurate to prevent urinary tract infections in community adult women: a systematic review and meta-analysis.
1
—
—